Comment on

• Impact of disease progression on individual IPSS trajectories and consequences of immediate versus delayed start of treatment in patients with moderate or severe LUTS associated with BPH.

  D'Agate S, Wilson T, Adalig B, Manyak M, Palacios-Moreno JM, Chavan C, Oelke M, Roehrborn C, Della Pasqua O. D'Agate S, et al. World J Urol. 2020 Feb;38(2):463-472. doi: 10.1007/s00345-019-02783-x. Epub 2019 May 11. World J Urol. 2020. PMID: 31079189 Free PMC article. Clinical Trial.
• Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?

  Novara G, Checcucci E, Crestani A, Abrate A, Esperto F, Pavan N, De Nunzio C, Galfano A, Giannarini G, Gregori A, Liguori G, Bartoletti R, Porpiglia F, Scarpa RM, Simonato A, Trombetta C, Tubaro A, Ficarra V; Research Urology Network (RUN). Novara G, et al. Eur Urol. 2020 Dec;78(6):786-811. doi: 10.1016/j.eururo.2020.06.025. Epub 2020 Jun 18. Eur Urol. 2020. PMID: 32616405 Free PMC article.
• Patient Perspectives on Benign Prostatic Hyperplasia Surgery: A Focus on Sexual Health.

  Bouhadana D, Nguyen DD, Zorn KC, Elterman DS, Bhojani N. Bouhadana D, et al. J Sex Med. 2020 Oct;17(10):2108-2112. doi: 10.1016/j.jsxm.2020.07.006. Epub 2020 Aug 6. J Sex Med. 2020. PMID: 32773345
• Escherichia coli, a common constituent of benign prostate hyperplasia-associated microbiota induces inflammation and DNA damage in prostate epithelial cells.

  Jain S, Samal AG, Das B, Pradhan B, Sahu N, Mohapatra D, Behera PK, Satpathi PS, Mohanty AK, Satpathi S, Senapati S. Jain S, et al. Prostate. 2020 Nov;80(15):1341-1352. doi: 10.1002/pros.24063. Epub 2020 Aug 24. Prostate. 2020. PMID: 32835423